Lipella Pharmaceuticals Inc.
11
Jeffery A. Deller
03/30/2026
11/13/2026
Yes
v
| Sale |
Assigned to: Judge Jeffery A. Deller Chapter 11 Voluntary Asset |
|
Debtor Lipella Pharmaceuticals Inc.
1159 S. Negley Avenue Pittsburgh, PA 15217 ALLEGHENY-PA Tax ID / EIN: 20-2388040 |
represented by |
Michael A. Shiner
Tucker Arensberg 1500 One PPG Place Pittsburgh, PA 15222 412-566-1212 Fax : 412-594-5619 Email: mshiner@tuckerlaw.com Joanna Studeny
Tucker Arensberg, P.C. 1500 One PPG Place Pittsburgh, PA 15222 404-386-9521 Email: jstudeny@tuckerlaw.com Maribeth Thomas
Tucker Arensberg PC 1500 One PPG Place Pittsburgh, PA 15222 412-594-3949 Fax : 412-594-5619 Email: mthomas@tuckerlaw.com |
U.S. Trustee Office of the United States Trustee
1000 Liberty Avenue Suite 1316 Pittsburgh, PA 15222 412-644-4756 |
represented by |
William M. Buchanan
DOJ-Ust 1000 Liberty Avenue Ste 1316 Pittsburgh, PA 15222 412-644-4779 Email: william.buchanan@usdoj.gov |
| Date Filed | # | Docket Text |
|---|---|---|
| 11/13/2026 | 197 | Objection to Confirmation of Plan Limited Objection Plan Dated 09/21/2026. Hearing Set For 11/24/2026. Filed by Office of the United States Trustee (RE: related document(s): [168] Disclosure Statement, [169] Chapter 11 Plan, [187] Chapter 11 Plan, [188] Disclosure Statement). (Attachments: # (1) Proposed Order # (2) Certificate of Service)(Buchanan, William) |
| 11/05/2026 | 196 | Certificate of Service of Solicitation Package (served October 16, 2026) Filed by Debtor Lipella Pharmaceuticals Inc. (RE: related document(s): [187] Chapter 11 Plan filed by Debtor Lipella Pharmaceuticals Inc., [188] Disclosure Statement filed by Debtor Lipella Pharmaceuticals Inc.). (Shiner, Michael) |
| 10/31/2026 | 195 | BNC Certificate of Mailing - PDF Document. (RE: related document(s): [186] Order on Motion for Pro Hac Vice Admission). Notice Date 10/30/2026. (Admin.) |
| 10/23/2026 | 194 | CORRECTIVE ENTRY: PLEASE REFILE ENSURING TO INCLUDE ELECTRONIC SIGNATURES IN COMPLIANCE WITH W.PA.LBR 5005-6, SPECIFICALLY USING A TYPED /S/. (RE: related document(s): [191] Chapter 11 Monthly Operating Report UST Form 11-MOR filed by Debtor Lipella Pharmaceuticals Inc.). (kdoy) |
| 10/21/2026 | 193 | Text Order Signed on 10/21/2026 by Judge Jeffery A. Deller. AND NOW, this 21st day of October, 2026, upon consideration of the Debtors Response to Order to Show Cause [Doc. No. 192], and following review of the statements contained therein and the redline comparisons attached thereto as Exhibits A and B, the Court is satisfied that the modifications to the Plan and Disclosure Statement are consistent with the matters discussed on the record at the hearing held on October 13, 2026. Accordingly, the Rule to Show Cause issued at Doc. No. 190 is hereby DISCHARGED. The Courts prior Order conditionally approving the Disclosure Statement and establishing solicitation and confirmation procedures shall remain in full force and effect. (RE: related document(s): [192] Response). (jfur) |
| 10/21/2026 | 192 | Response to Order to Show Cause Regarding the Hearing on 11/24/2026. Filed by Lipella Pharmaceuticals Inc. (RE: related document(s): [190] Order Scheduling Hearing). (Attachments: # (1) Exhibit A - Redlined Plan (Solicitation) # (2) Exhibit B - Redlined Disclosure Statement (Solicitation)) (Shiner, Michael) |
| 10/20/2026 | 191 | Chapter 11 Monthly Operating Report for the Month Ending: 09/30/2026 Filed by Debtor Lipella Pharmaceuticals Inc. (Attachments: # (1) SUMMARY OF CASH RECEIPTS AND DISBURSEMENTS # (2) BALANCE SHEET # (3) INCOME STATEMENT # (4) BANK RECONCILIATION # (5) ACCRUED PAYROLL # (6) BANK STATEMENT) (Thomas, Maribeth) |
| 10/19/2026 | 190 | ORDER TO SHOW CAUSE (RE: related document(s): [183] Order Scheduling Hearing, [187] Chapter 11 Plan filed by Debtor Lipella Pharmaceuticals Inc., [188] Disclosure Statement filed by Debtor Lipella Pharmaceuticals Inc., [189] Exhibit filed by Debtor Lipella Pharmaceuticals Inc.). The Debtor shall SHOW CAUSE why the Court should not vacate its October 13, 2026 Order (ECF No. 183) and schedule a new hearing to consider conditional approval of the Disclosure Statement filed at ECF No. 188, together with appropriate revised solicitation, voting, objection, and confirmation procedures and deadlines. Responses due by 10/27/2026. (kdoy) |
| 10/16/2026 | 189 | Exhibit B to Disclosure Statement Filed by Debtor Lipella Pharmaceuticals Inc. (RE: related document(s): [188] Disclosure Statement filed by Debtor Lipella Pharmaceuticals Inc.). (Shiner, Michael) |
| 10/16/2026 | 188 | Disclosure Statement to Accompany Chapter 11 Plan of Liquidation of Lipella Pharmaceuticals, Inc. [ECF No. 187] Filed by Lipella Pharmaceuticals Inc. (Shiner, Michael) |